ivabradine has been researched along with Angina Pectoris in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 44 (48.89) | 29.6817 |
2010's | 45 (50.00) | 24.3611 |
2020's | 1 (1.11) | 2.80 |
Authors | Studies |
---|---|
Chen, T; Fang, X; Huang, J; Xu, X; Zhao, Q; Zheng, J; Zhu, H | 1 |
Gluud, C; Jakobsen, JC; Maagaard, M; Nielsen, EE; Ning, L; Sethi, NJ; Yang, SH | 1 |
Bouvaist, H; Cosgrove, S; Ennezat, PV; Le Jemtel, TH; Marechaux, S; Vital Durand, D | 1 |
Crea, F; Di Franco, A; Di Monaco, A; Lamendola, P; Lanza, GA; Nerla, R; Sarullo, FM; Sestito, A; Tarzia, P; Villano, A | 1 |
Jacobshagen, C | 1 |
Jones, DA; Timmis, A; Wragg, A | 1 |
Bourke, JP; Keavney, BD; Koref, MS; Martin, RI; Pogoryelova, O; Teare, MD | 1 |
Cowie, MR | 1 |
Lohmann, M | 1 |
Chassany, O; Ferrari, R; Ford, I; Fox, K; Steg, PG; Tardif, JC; Tendera, M | 1 |
Hu, D; Sun, Y; Yu, J | 1 |
Nguyen, E; Weeda, ER; White, CM | 1 |
Colombo, A; Fragasso, G; Fumero, A; Giannini, F; Godino, C; Maranta, F; Margonato, A; Oppizzi, M; Slavich, M | 1 |
Fortmüller, U | 1 |
de Silva, R; Giavarini, A | 1 |
Alshammari, TM | 1 |
Astashkin On Behalf Of The Linkor Study Investigators, EI; Glezer, MG | 1 |
Tardif, JC | 2 |
Deev, AD; Karpov, IuA | 1 |
Biriuchenko, MV; Pozdniakova, NV; Tatarchenko, IP | 1 |
Arora, R; Jawad, E | 1 |
van de Borne, P | 1 |
Stieber, J | 1 |
Kahan, T; Ponikowski, P; Tardif, JC | 1 |
D'Orazio, N; Riccioni, G; Vitulano, N | 1 |
Sajadieh, A | 1 |
Riccioni, G | 2 |
Fomin, IV; Valikulova, FIu | 1 |
Gray, D; Prasad, UK; Purcell, H | 1 |
de Silva, R; Fox, KM | 1 |
Borer, JS; Tardif, JC; Tendera, M | 1 |
Ferrari, R; Ford, I; Fox, K; Robertson, M; Steg, PG; Tendera, M | 1 |
Kaehler, J; Köster, R; Meinertz, T | 1 |
Borer, JS; Tardif, JC | 1 |
Lopatin, IuM | 2 |
D'Angelo, L; Fazio, G; Licata, P; Novo, G; Novo, S; Passantino, S; Sarulo, F; Spanò, C; Visconti, C; Zarcone, P | 1 |
Ebelt, H; Kaehler, J; Koester, R; Meinertz, T; Soeffker, G; Werdan, K | 1 |
Battler, A; Dvir, D | 1 |
Kaehler, J; Koester, R; Meinertz, T | 1 |
Lebedev, EV; Shkol'nik, EL; Vasiuk, IuA | 1 |
Bhargava, B; Parakh, N | 1 |
Kosheleva, NA; Rebrov, AP | 1 |
Ageev, FT; Makarova, GV; Orlova, IaA; Patrusheva, IF | 1 |
Massé, JF | 1 |
Feola, M; Lombardo, E; Menditto, E; Nervo, E; Piccolo, S; Taglieri, C | 1 |
Glezer, MG; Saĭgitov, RT | 1 |
Köster, R; Meinertz, T | 1 |
Mach, F | 1 |
Carbajal, EV; Deedwania, PC | 1 |
Bonadei, I; Bontempi, L; Curnis, A; D'Aloia, A; Dei Cas, L; Del Magro, F; Piovanelli, B; Vizzardi, E | 1 |
Athanasiadis, A; Sechtem, U | 1 |
Anzai, T | 1 |
Boissel, JP; Chabaud, S; Girard, P; Nony, P | 1 |
Borer, JS; Fox, K; Jaillon, P; Lerebours, G | 1 |
Er, F; Hoppe, UC | 1 |
Bourassa, MG; Ford, I; Fox, K; Tardif, JC; Tendera, M | 1 |
Marber, MS; Saha, M | 1 |
Borer, JS | 3 |
Barsness, GW; Yang, EH | 1 |
Sulfi, S; Timmis, AD | 1 |
Fox, K | 1 |
Hennersdorf, MG | 1 |
Diaz, A; Tardif, JC | 1 |
Camm, AJ; Savelieva, I | 1 |
Belousov, IuB; Erofeeva, SB; Maneshina, OA | 1 |
Hoppe, UC | 1 |
Haghfelt, TH | 1 |
Barbuti, A; Baruscotti, M; Bucchi, A; DiFrancesco, D | 1 |
Ford, I; Fox, KM; Ruzyllo, W; Tendera, M | 1 |
César, LA | 1 |
Menown, IB | 1 |
Filipova, S; López-Bescós, L; Martos, R | 1 |
Andrikopoulos, G; Dasopoulou, C; Kappos, K; Koulouris, S; Kranidis, A; Manolis, AS; Sakellariou, D; Tzeis, S | 1 |
Chaitman, BR; Sano, J | 1 |
Izzat, LM | 1 |
42 review(s) available for ivabradine and Angina Pectoris
Article | Year |
---|---|
Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
Topics: Angina Pectoris; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2019 |
Effects of adding ivabradine to usual care in patients with angina pectoris: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.
Topics: Aged; Angina Pectoris; Cardiovascular Agents; Female; Humans; Ivabradine; Male; Middle Aged; Patient Safety; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome | 2020 |
Limited role and benefit of ivabradine in the treatment of angina and heart failure with reduced ejection fraction.
Topics: Angina Pectoris; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome | 2017 |
[Late sodium current and calcium overload--pathogenesis and adequate treatment].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Atrial Fibrillation; Benzazepines; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Electrocardiography; Endothelium, Vascular; Heart Failure, Diastolic; Humans; Hypercalcemia; Ivabradine; Myocardial Ischemia; Nitrates; Piperazines; Ranolazine; Sodium; Sodium Channels; Sodium-Calcium Exchanger | 2013 |
Novel drugs for treating angina.
Topics: Acetanilides; Angina Pectoris; Benzazepines; Enzyme Inhibitors; Heart Rate; Humans; Ivabradine; Nicorandil; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2013 |
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.
Topics: Angina Pectoris; Atrial Fibrillation; Benzazepines; Heart Failure; Humans; Incidence; Ivabradine; Randomized Controlled Trials as Topic; Risk Assessment | 2014 |
Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease.
Topics: Angina Pectoris; Benzazepines; Canada; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Myocardial Infarction; Stroke Volume; Treatment Outcome | 2016 |
The Role of Ivabradine in the Management of Angina Pectoris.
Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Heart Rate; Humans; Ivabradine | 2016 |
Ivabradine: Do the Benefits Outweigh the Risks?
Topics: Angina Pectoris; Benzazepines; Bradycardia; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Patient Safety; Recovery of Function; Risk Assessment; Risk Factors; Treatment Outcome; Ventricular Function, Left | 2017 |
Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
Topics: Angina Pectoris; Animals; Benzazepines; Cardiotonic Agents; Cardiovascular Diseases; Heart Rate; Humans; Ivabradine | 2008 |
Chronic stable angina pectoris.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetanilides; Angina Pectoris; Antihypertensive Agents; Benzazepines; Bosentan; Chronic Disease; Counterpulsation; Cyclic Nucleotide-Gated Cation Channels; Exercise Test; Heart Murmurs; Humans; Ivabradine; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Nicorandil; Oxygen Consumption; Perhexiline; Piperazines; Protein Kinase Inhibitors; Ranolazine; Sulfonamides; Trimetazidine; Vasodilator Agents | 2008 |
[What are the alternatives to betablockers in 2009?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiomyopathies; Heart Failure; Heart Valve Diseases; Humans; Ivabradine; Myocardial Infarction; Myocardial Ischemia; Patient Selection; Stereoisomerism; Vasodilator Agents | 2008 |
Ivabradine for stable angina?
Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Humans; Ivabradine; Treatment Outcome | 2008 |
Ivabradine: pharmacodynamic aspects of its clinical use.
Topics: Angina Pectoris; Animals; Benzazepines; Chronic Disease; Cyclic Nucleotide-Gated Cation Channels; Heart Rate; Humans; Ion Channels; Ivabradine | 2008 |
Ivabradine: beyond heart rate control.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Heart Failure; Heart Rate; Heart Transplantation; Humans; Ivabradine; Nitrates; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left | 2009 |
Focus on ivabradine: a new heart rate-controlling drug.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Heart Rate; Humans; Ivabradine; Risk Factors; Vision Disorders | 2009 |
Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
Topics: Action Potentials; Angina Pectoris; Benzazepines; Chronic Disease; Cyclic Nucleotide-Gated Cation Channels; Exercise Test; Heart Rate; Humans; Ivabradine; Membrane Transport Modulators; Patient Selection; Quality of Life; Safety; Sinoatrial Node; Treatment Outcome | 2009 |
Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
Topics: Age Distribution; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Coronary Artery Bypass; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Humans; Incidence; Ivabradine; Male; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Severity of Illness Index; Sex Distribution; Survival Rate; Treatment Outcome | 2009 |
[Ivabradine in the treatment of patients with angina pectoris: lessons of the BEAUTIFUL trial].
Topics: Angina Pectoris; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Humans; Ivabradine; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Conventional and novel drug therapeutics to relief myocardial ischemia.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Cardiovascular System; Coronary Artery Disease; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Nicorandil; Nitrates; Piperazines; Ranolazine | 2010 |
Rate control with ivabradine: angina pectoris and beyond.
Topics: Acute Coronary Syndrome; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Heart Failure; Heart Rate; Humans; Ivabradine | 2011 |
Ivabradine: recent and potential applications in clinical practice.
Topics: Angina Pectoris; Animals; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Risk Factors; Ventricular Dysfunction, Left | 2011 |
[From results of BEAUTIFUL trial to results of SHIFT trial: BEAUTIFUL possibility to make a SHIFT in current guidelines].
Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Disease Progression; Evidence-Based Medicine; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2011 |
[New agents for the therapy of angina pectoris].
Topics: Acetanilides; Angina Pectoris; Benzazepines; Coronary Artery Disease; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Drug Approval; Enzyme Inhibitors; Humans; Ivabradine; Nicorandil; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Vasodilator Agents | 2011 |
Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Ivabradine; Myocardial Revascularization; Nitrates; Piperazines; Ranolazine; Treatment Outcome | 2011 |
The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Cyclic Nucleotide-Gated Cation Channels; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Prognosis; Sinoatrial Node | 2011 |
[Ivabradine (pure heart-rate-lowering agent)].
Topics: Angina Pectoris; Animals; Benzazepines; Heart Failure; Heart Rate; Humans; Ivabradine; Mice | 2011 |
Ivabradine for chronic heart failure?
Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Drug insight: If inhibitors as specific heart-rate-reducing agents.
Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Electric Conductivity; Heart; Heart Rate; Humans; Ion Channel Gating; Ion Channels; Ivabradine; Myocardial Contraction; Sinoatrial Node | 2004 |
Evolving treatment strategies for chronic refractory angina.
Topics: Acetanilides; Angina Pectoris; Arginine; Benzazepines; Cardiovascular Agents; Chronic Disease; Combined Modality Therapy; Counterpulsation; Electric Stimulation Therapy; Humans; Ivabradine; Myocardial Revascularization; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Spinal Cord | 2006 |
Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
Topics: Angina Pectoris; Animals; Anti-Arrhythmia Agents; Benzazepines; Drug Therapy, Combination; Humans; Ivabradine; Maximum Tolerated Dose; Randomized Controlled Trials as Topic; Sinoatrial Node | 2006 |
Therapeutic effects of I(f) blockade: evidence and perspective.
Topics: Angina Pectoris; Animals; Benzazepines; Heart Rate; Humans; Ion Channels; Ivabradine; Myocardial Ischemia; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left | 2006 |
Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradine.
Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Clinical Trials as Topic; Heart Conduction System; Heart Rate; Humans; Ion Channels; Ivabradine; Placebos | 2006 |
Heart rate slowing versus other pharmacological antianginal strategies.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Cardiotonic Agents; Clinical Trials as Topic; Heart Conduction System; Heart Rate; Humans; Ion Channels; Ivabradine; Nitrates; Placebos | 2006 |
Novel If current inhibitor ivabradine: safety considerations.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Automobile Driving; Benzazepines; Bradycardia; Cardiotonic Agents; Cardiovascular Diseases; Clinical Trials as Topic; Eye; Heart Conduction System; Heart Rate; Humans; Ion Channels; Ivabradine; Sinoatrial Node | 2006 |
[Ivabradine--the first selective and specific I(f) inhibitor, novel preparation for treatment of stable angina].
Topics: Angina Pectoris; Benzazepines; Heart Rate; Humans; Ivabradine; Sinoatrial Node; Stereoisomerism; Treatment Outcome | 2006 |
Heart rate reduction via selective 'funny' channel blockers.
Topics: Angina Pectoris; Animals; Anti-Arrhythmia Agents; Benzazepines; Coronary Artery Disease; Drug Delivery Systems; Heart Rate; Humans; Ion Channel Gating; Ion Channels; Ivabradine; Sinoatrial Node | 2007 |
I(f) current and heart rate control.
Topics: Action Potentials; Angina Pectoris; Animals; Benzazepines; Calcium Channels; Cyclic Nucleotide-Gated Cation Channels; Electric Conductivity; Heart Rate; Humans; Ivabradine; Membrane Potentials; Rabbits; Sinoatrial Node; Sodium Channels | 2007 |
Ivabradine: a new strategy for management of stable angina.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium Channel Blockers; Clinical Trials as Topic; Exercise Tolerance; Humans; Ivabradine; Treatment Outcome | 2007 |
Clinical results of I(f) current inhibition by ivabradine.
Topics: Angina Pectoris; Benzazepines; Coronary Disease; Electrophysiology; Heart Failure; Heart Rate; Humans; Ion Channels; Ivabradine; Potassium; Sodium | 2007 |
Ivabradine: a selective If current inhibitor in the treatment of stable angina.
Topics: Angina Pectoris; Animals; Benzazepines; Clinical Trials as Topic; Cyclic Nucleotide-Gated Cation Channels; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; Ivabradine; Muscle Proteins; Potassium Channels; Sinoatrial Node | 2006 |
Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Chronic Disease; Enzyme Inhibitors; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Nitro Compounds; Piperazines; Ranolazine; rho-Associated Kinases; Sinoatrial Node; Trimetazidine; Vasodilator Agents | 2007 |
19 trial(s) available for ivabradine and Angina Pectoris
Article | Year |
---|---|
Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
Topics: Acetanilides; Analysis of Variance; Angina Pectoris; Benzazepines; Chi-Square Distribution; Coronary Angiography; Enzyme Inhibitors; Exercise Test; Female; Humans; Ivabradine; Male; Middle Aged; Piperazines; Placebos; Quality of Life; Ranolazine; Surveys and Questionnaires; Treatment Outcome | 2013 |
[Relieve your patients of angina pectoris symptoms].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Drug Therapy, Combination; Humans; Ivabradine; Recurrence | 2015 |
Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life Substudy.
Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Female; Humans; Ivabradine; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Visual Analog Scale | 2016 |
[Status of β-blocker use and heart rate control in Chinese patients with stable coronary artery disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Blood Pressure; Coronary Angiography; Coronary Artery Disease; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Outpatients; Percutaneous Coronary Intervention; Prospective Studies; Registries; Risk Factors | 2016 |
[Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Benzazepines; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Ivabradine; Male; Stereoisomerism; Treatment Outcome | 2008 |
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Benzazepines; Blood Pressure; Cardiovascular Agents; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ion Channels; Ivabradine; Male; Middle Aged; Sinoatrial Node; Treatment Outcome; Young Adult | 2009 |
[Antianginal effect of long-term use of ivabradine in patients with ischemic heart disease and diabetes in ambulatory conditions].
Topics: Adrenergic Antagonists; Aged; Ambulatory Care; Angina Pectoris; Benzazepines; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome | 2009 |
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Coronary Artery Disease; Death, Sudden, Cardiac; Double-Blind Method; Female; Hospitalization; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left; Young Adult | 2009 |
Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.
Topics: Aged; Angina Pectoris; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Germany; Heart Rate; Humans; Ivabradine; Male; Prospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2009 |
Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
Topics: Angina Pectoris; Benzazepines; Blood Glucose; Cyclic Nucleotide-Gated Cation Channels; Diabetes Mellitus; Double-Blind Method; Electrocardiography; Exercise Tolerance; Female; Follow-Up Studies; Humans; Ivabradine; Male; Middle Aged; Treatment Outcome | 2010 |
Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzazepines; Drug Therapy, Combination; Female; Humans; Ivabradine; Male; Membrane Transport Modulators; Middle Aged; Treatment Outcome | 2010 |
Ivabradine for the treatment of stable angina pectoris in octogenarians.
Topics: Aged, 80 and over; Angina Pectoris; Benzazepines; Bradycardia; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Ivabradine; Male | 2011 |
[Dynamics of structural functional parameters of cardiovascular system in patients with Stable Angina and Congestive Heart Failure treated with Ivabradine for six months].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Benzazepines; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Endothelium; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Treatment Outcome; von Willebrand Factor | 2010 |
[The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
Topics: Administration, Inhalation; Adrenergic beta-1 Receptor Antagonists; Aged; Angina Pectoris; Benzazepines; Bisoprolol; Bronchodilator Agents; Cyclic Nucleotide-Gated Cation Channels; Drug Dosage Calculations; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Monitoring, Physiologic; Patient Readmission; Pulmonary Disease, Chronic Obstructive; Quality of Life; Treatment Outcome | 2010 |
[Antianginal efficacy and tolerability of ivabradine in the therapy of patients with stable angina: results of the CONTROL study].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Depression, Chemical; Drug Monitoring; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Prognosis; Severity of Illness Index; Treatment Outcome | 2010 |
Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzazepines; Depression, Chemical; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Sinoatrial Node; Treatment Outcome; Vision Disorders | 2003 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Exercise Tolerance; Female; Heart Conduction System; Humans; Ion Channels; Ivabradine; Male; Middle Aged | 2005 |
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Topics: Aged; Amlodipine; Angina Pectoris; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Double-Blind Method; Electrocardiography; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Nitrates | 2007 |
Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Female; Humans; Ivabradine; Male; Middle Aged; Treatment Outcome | 2007 |
29 other study(ies) available for ivabradine and Angina Pectoris
Article | Year |
---|---|
Ivabradine and atrial fibrillation: what should we tell our patients?
Topics: Angina Pectoris; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Heart Failure; Heart Rate; Humans; Ivabradine; Medication Therapy Management; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment | 2014 |
[Symptomatic coronary heart disease. Therapy with a beta blocker and ivabradine combination].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Coronary Disease; Drug Therapy, Combination; Guideline Adherence; Heart Failure; Humans; Ivabradine; Survival Rate | 2014 |
[Symptomatic coronary heart diseases. Combination therapy is successful in general practice].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Clinical Trials as Topic; Coronary Disease; Drug Combinations; Heart Rate; Humans; Ivabradine | 2014 |
Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy.
Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Echocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Ivabradine; Male; Myocardial Ischemia; Ranolazine; Retrospective Studies; Sodium Channel Blockers; Stroke Volume; Systole; Time Factors; Tomography, Emission-Computed, Single-Photon; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2016 |
[First fixed combination becomes available].
Topics: Angina Pectoris; Benzazepines; Coronary Disease; Drug Combinations; Humans; Ivabradine; Metoprolol | 2016 |
[Anti-angina fixed combination is available].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Cardiovascular Agents; Combined Modality Therapy; Coronary Disease; Drug Combinations; Humans; Ivabradine; Metoprolol; Recurrence | 2016 |
[Increased physical capacity].
Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Combinations; Humans; Ivabradine; Metoprolol; Physical Fitness | 2016 |
[Causes of Angina Pectoris in Survivors of Myocardial Infarction and the Role of Optimization of Antianginal Therapy. Data of the LINKOR Study E..]
Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Female; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Quality of Life; Risk Factors | 2016 |
[The program ALTERNATIVA--investigation of antianginal efficacy and tolerability of coraxan (ivabradine) and assessment of quality of life of patients with stable angina: results of an epidemiological stage].
Topics: Angina Pectoris; Benzazepines; Female; Follow-Up Studies; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Morbidity; Quality of Life; Retrospective Studies; Russia; Stereoisomerism; Treatment Outcome | 2008 |
A new combination therapy in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Drug Therapy, Combination; Humans; Ivabradine; Treatment Outcome | 2009 |
Angina: Ivabradine for treatment of stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Chronic Disease; Drug Therapy, Combination; Exercise Tolerance; Heart Rate; Humans; Ivabradine; Treatment Outcome | 2009 |
Ivabradine versus bisoprolol.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Bisoprolol; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2010 |
[Stable angina pectoris. Effective symptom control and cardioprotection with ivabradine].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Drug Therapy, Combination; Humans; Ivabradine; Randomized Controlled Trials as Topic | 2010 |
[Possibilities of if channels inhibitor ivabradine in complex treatment of survivors of myocardial infarction with stable angina].
Topics: Aged; Angina Pectoris; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Echocardiography; Follow-Up Studies; Humans; Ivabradine; Middle Aged; Myocardial Infarction; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Stable angina: role of ivabradine unchanged between 2006 and 2010.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Drug Therapy, Combination; Humans; Ivabradine; Randomized Controlled Trials as Topic | 2010 |
[Antianginal efficacy of ivabradine in a very old patient with aortic stenosis: effects on cardiac output and transvalvular aortic gradients].
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Angina Pectoris; Aortic Valve Stenosis; Benzazepines; Cardiotonic Agents; Drug Therapy, Combination; Humans; Ivabradine; Male; Myocardial Infarction | 2010 |
Ivabradine in combination with a beta-blocker. Stable angina: do not use instead, of or, with a beta-blocker.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Drug Therapy, Combination; Humans; Ivabradine | 2010 |
[Angina pectoris: improving symptoms and prognosis. With ivabradine less angina pectoris and reduced need for nitrates].
Topics: Angina Pectoris; Benzazepines; Drug Therapy, Combination; Heart Rate; Hemodynamics; Humans; Ivabradine; Nitric Oxide Donors; Prognosis; Randomized Controlled Trials as Topic; Vasodilator Agents | 2011 |
[Reducing heart rate to treat angina pectoris].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Benzazepines; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic | 2011 |
[Update coronary artery disease: important progresses in acute and chronic therapy].
Topics: Acetanilides; Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Coronary Artery Disease; Early Medical Intervention; Humans; Ivabradine; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ranolazine; Survival Rate; Thrombolytic Therapy | 2012 |
Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectoris.
Topics: Angina Pectoris; Benzazepines; Chi-Square Distribution; Clinical Trials, Phase III as Topic; Double-Blind Method; Humans; Ivabradine; Models, Biological; Monte Carlo Method; Randomized Controlled Trials as Topic | 2002 |
[Ivabradine -- a novel approach for heart rate lowering].
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Contraindications; Electrocardiography; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Infarction; Randomized Controlled Trials as Topic; Sinoatrial Node; Treatment Outcome; Ventricular Function, Left | 2005 |
If at first you don't succeed try ... a new target in the treatment of angina.
Topics: Angina Pectoris; Benzazepines; Chronic Disease; Humans; Ion Channels; Ivabradine | 2005 |
Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Heart Rate; Humans; Ivabradine; Myocardial Ischemia; Nitrates; Randomized Controlled Trials as Topic; Sinoatrial Node | 2006 |
[Possibilities of reducing heart rate by I(f)-channel inhibitors].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Benzazepines; Cause of Death; Cyclic Nucleotide-Gated Cation Channels; Electrocardiography; Exercise Test; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; Ivabradine; Muscle Proteins; Myocardial Infarction; Potassium Channels; Prognosis; Randomized Controlled Trials as Topic; Sinoatrial Node; Stereoisomerism; Tachycardia | 2006 |
[A new medicine for treatment of stable angina pectoris].
Topics: Angina Pectoris; Benzazepines; Cardiotonic Agents; Heart Rate; Humans; Ivabradine | 2006 |
[Heart rate reduction as a therapeutic strategy: novel options].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Coronary Disease; Electrocardiography; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Contraction; Survival Rate | 2006 |
[Ivabradine--a medical alternative for patients with chronic stable angina pectoris].
Topics: Angina Pectoris; Benzazepines; Chronic Disease; Humans; Ivabradine | 2006 |
The role of heart rate reduction in angina management and beyond.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Heart Rate; Humans; Ivabradine; Risk Factors | 2008 |